3:19-cv-05939 - Dow Pharmaceutical Sciences Inc et al. v. Apotex Inc

Detail

Case Number

3:19-cv-05939

Current Status

closed

Cause of Action

Infringement

Related Case(s)

3:18-cv-13635

3:18-cv-13693

3:18-cv-13696

3:18-cv-13700

3:18-cv-13905

3:18-cv-13954

3:18-cv-14202

3:18-cv-14208

3:18-cv-14209

3:18-cv-14225

3:18-cv-14298

3:18-cv-14305

3:18-cv-14468

3:18-cv-15060

3:18-cv-17246

3:18-cv-17501

3:18-cv-17731

3:18-cv-17733

3:19-cv-00133

3:19-cv-00988

3:19-cv-00990

3:19-cv-05162

3:19-cv-08218

3:19-cv-08233

Court

New Jersey District Court

Plaintiff(s)

Dow Pharmaceutical Sciences Inc

Valeant Pharmaceuticals North America LLC

Kaken Pharmaceutical Co Ltd

Valeant Pharmaceuticals Ireland Ltd

Operating Company

Defendant(s)

Apotex Inc

Judge

Peter G. Sheridan

Filing Date

2019-02-15

Termination Date

2019-04-15

Not a member? Sign up for free!
Dockets
Text
CIVIL DOCKET
UPDATED CIVIL DOCKET
***Civil Case Terminated. (mps) (Entered: 04/16/2019)
COMPLAINT against APOTEX CORP., APOTEX INC. ( Filing and Admin fee $ 400 receipt number 0312-9423384), filed by VALEANT PHARMACEUTICALS NORTH AMERICA LLC, KAKEN PHARMACEUTICAL CO., LTD., DOW PHARMACEUTICAL SCIENCES, INC., VALEANT PHARMACEUTICALS IRELAND LTD.. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet, # 3 L. Civ. R. 11.2 Certification)(DENI, WILLIAM) (Entered: 02/15/2019)
Corporate Disclosure Statement by DOW PHARMACEUTICAL SCIENCES, INC., VALEANT PHARMACEUTICALS IRELAND LTD., VALEANT PHARMACEUTICALS NORTH AMERICA LLC identifying Bausch Health Companies Inc. as Corporate Parent.. (DENI, WILLIAM) (Entered: 02/15/2019)
Corporate Disclosure Statement by KAKEN PHARMACEUTICAL CO., LTD.. (DENI, WILLIAM) (Entered: 02/15/2019)
AO120 Patent Form filed. (jmh) (Entered: 02/19/2019)
SUMMONS ISSUED as to APOTEX CORP., APOTEX INC.. Attached is the official court Summons, please fill out Defendant and Plaintiffs attorney information and serve. (jmh) (Entered: 02/19/2019)
NOTICE of Appearance by J. BRUGH LOWER on behalf of DOW PHARMACEUTICAL SCIENCES, INC., KAKEN PHARMACEUTICAL CO., LTD., VALEANT PHARMACEUTICALS IRELAND LTD., VALEANT PHARMACEUTICALS NORTH AMERICA LLC (LOWER, J.) (Entered: 02/26/2019)
ORDER SCHEDULING CONFERENCE: Scheduling Conference set for 3/21/2019 10:00 AM in Trenton - Courtroom 7E before Magistrate Judge Lois H. Goodman. Signed by Magistrate Judge Lois H. Goodman on 3/5/2019. (mps) (Entered: 03/05/2019)
WAIVER OF SERVICE Returned Executed by VALEANT PHARMACEUTICALS NORTH AMERICA LLC, KAKEN PHARMACEUTICAL CO., LTD., DOW PHARMACEUTICAL SCIENCES, INC., VALEANT PHARMACEUTICALS IRELAND LTD.. APOTEX INC. waiver sent on 2/28/2019, answer due 5/29/2019. (DENI, WILLIAM) (Entered: 03/06/2019)
WAIVER OF SERVICE Returned Executed by VALEANT PHARMACEUTICALS NORTH AMERICA LLC, KAKEN PHARMACEUTICAL CO., LTD., DOW PHARMACEUTICAL SCIENCES, INC., VALEANT PHARMACEUTICALS IRELAND LTD.. APOTEX CORP. waiver sent on 2/28/2019, answer due 4/29/2019. (DENI, WILLIAM) (Entered: 03/06/2019)
ORDER CONSOLIDATING CASES FOR ALL PURPOSES. Civil Action No. 18-13635 shall be the Lead Case and effective upon entry of this order, all filings in the Consolidated Actions are to be made only in Civil Action No. 18-13635. Signed by Judge Peter G. Sheridan on 4/15/2019. (mmh) (Entered: 04/16/2019)
Timeline
filed_date
closed_date
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
2020
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
2021
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
2022
Patents In Case

Not a member? Sign up for free!